FINWIRES · TerminalLIVE
FINWIRES

BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range

By

BLS Pharmaceuticals (ASX:BLS) reported record quarterly revenue of AU$22.5 million for the three months through June, up 5% from the previous quarter, according to a Monday filing with the Australian bourse.

The quarterly sales brought fiscal 2026 revenue to about AU$75 million, 156% above the previous fiscal year and hitting the top end of the company's guidance range, per the filing.

The company further reported record fiscal 2026 adjusted earnings before interest, taxes, depreciation, and amortization of AU$19 million, an increase of 190% from the prior year and also at the top end of its guidance range.

Additionally, BLS Pharmaceuticals increased its cash balance to AU$13.3 million at the close of June from AU$8.5 million as of March 31.

The company's shares gained over 1% in recent Monday trade.

Related Articles

Asia

Market Chatter: India's State Oil Firms Buy Additional Oil from Spot Market Amid Potential Middle East Supply Delays

Indian Oil (NSE:IOC, BOM:530965), Bharat Petroleum (NSE:BPCL, BOM:500547) and Hindustan Petroleum (NSE:HINDPETRO, BOM:500104) have made crude oil purchases from the spot market, Bloomberg reported Friday, citing people familiar with the matter.The move comes as a buffer for potential delays in shipments from Saudi Arabia and Iraq, according to the report.The Indian state-owned oil companies have been asked to tap into their stored supplies if needed to ensure undisrupted refinery operations in August and avoid fuel, especially cooking gas, shortages, the people reportedly told Bloomberg, asking to remain unnamed.Oil Minister Hardeep Singh Puri, on Thursday, had discussions on backup strategies with state-run refiners, Bloomberg said.Indian Oil, Bharat Petroleum and Hindustan Petroleum did not immediately respond to' requests for a comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

BOM:500104BOM:500547BOM:530965NSE:BPCLNSE:HINDPETRONSE:IOC
Asia

Japan Hotel REIT's Revenue Nearly Flat in June

Japan Hotel REIT Investment (TYO:8985) said its 29 hotels generated total revenue of 6.05 billion yen in June, down 0.6% from a year earlier.Hotel occupancy reached 81.2% in June, up 0.1% year over year, according to a Tokyo bourse filing on Friday.The average daily rate gained 1.6% to 18,509 yen, while revenue per available room rose 1.7% to 15,023 yen.

TYO:8985
Asia

Daiwa Office Investment Requests Rating Withdrawal

Daiwa Office Investment Corporation's (TYO:8976) has requested Rating and Investment Information Inc. withdraw its assigned AA- issuer rating following a cost-benefit review, according to a Tokyo bourse filing Friday.The AA long-term issuer rating by Japan Credit Rating Agency with a stable outlook is expected to remain effective.

TYO:8976